COVUX | VIHAX | COVUX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 9 years | - |
Gain YTD | 5.397 | 5.296 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.08B | 8.38B | 37% |
Annual Yield % from dividends | 3.53 | 4.87 | 72% |
Returns for 1 year | 13.26 | 11.72 | 113% |
Returns for 3 years | 10.25 | 6.35 | 161% |
Returns for 5 years | 20.56 | 17.95 | 115% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BIAQX | 11.83 | -0.03 | -0.25% |
Brown Advisory Emgerg Mkts Select Inv | |||
FIOOX | 17.43 | -0.07 | -0.40% |
Fidelity Series Large Cap Value Index | |||
HEMCX | 8.76 | -0.06 | -0.68% |
Janus Henderson Emerging Markets C | |||
GSWPX | 25.22 | -0.49 | -1.91% |
Goldman Sachs Small/Mid Cap Growth P | |||
STCIX | 8.67 | -0.21 | -2.36% |
Virtus Silvant Large-Cap Growth Stk A |